Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 25, 2017

DrugPatentWatch Database Preview

LORATADINE Drug Profile

« Back to Dashboard

What is the patent landscape for Loratadine, and what generic alternatives are available?

Loratadine is a drug marketed by Perrigo, Taro, Teva, Sandoz, Perrigo Pharma Intl, Marksans Pharma, Wockhardt, Silarx, Pfizer, Ranbaxy Labs Ltd, Sun Pharm Inds Ltd, Mylan, Apotex Inc, Taro Pharm, and Actavis Labs Fl Inc. and is included in twenty-seven NDAs.

The generic ingredient in LORATADINE is loratadine; pseudoephedrine sulfate. There are thirty-nine drug master file entries for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the loratadine; pseudoephedrine sulfate profile page.

Summary for Tradename: LORATADINE

Patents:0
Applicants:15
NDAs:27
Suppliers / Packagers: see list119
Bulk Api Vendors: see list83
Clinical Trials: see list9
Patent Applications: see list6,132
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:LORATADINE at DailyMed

Pharmacology for Tradename: LORATADINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo
LORATADINE
loratadine
TABLET;ORAL076301-001Jun 25, 2004OTCNoNo► Subscribe► Subscribe
Taro Pharm
LORATADINE
loratadine
SYRUP;ORAL201865-001Jul 31, 2015OTCNoNo► Subscribe► Subscribe
Perrigo Pharma Intl
LORATADINE AND PSEUDOEPHEDRINE SULFATE
loratadine; pseudoephedrine sulfate
TABLET, EXTENDED RELEASE;ORAL076050-001Jan 30, 2003OTCNoNo► Subscribe► Subscribe
Marksans Pharma
LORATADINE
loratadine
CAPSULE;ORAL206214-001Sep 23, 2016OTCNoNo► Subscribe► Subscribe
Sandoz
LORATADINE
loratadine
TABLET;ORAL075209-001Jan 21, 2003OTCNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot